Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Engage Grants Program

University of Saskatchewan

$23,926.00

Therapeutic biomaterial composites

EF 2010-11

Résumé
The aim of this study is to evaluate the possible chemical interactions between ternary mixtures of these chemicals for development of novel therapeutic biomaterial formulations, and to produce a commercially viable product. Novel types of biomaterial composites derived from binary mixtures of a polysaccharide and a bioactive ketone will be formulated to produce a novel hemostatic agent. The projected outcome of this NSERC Engage research is an increase in the understanding of the chemistry of these agents which will lead to a better manipulation and the formulation of new biomaterial composites which have potential therapeutic application in the prevention and treatment of dry sockets. The NSERC Engage program provides an opportunity to develop new research, by supporting the proposed short-term project aimed at the development of novel therapeutic biomaterial formulations, and to commercialize a viable commercial product. A major social benefit to Canada is the development of improved biomaterial composites to treat dry socket and for hemostatic materials. The market demand for these materials is very high, the materials are novel, possessing additional properties, not typically found in existing products, and will enable us to overcome some of the undesirable properties present in commercially available products. Therefore, the anticipated economic benefits are wide ranging and are anticipated to be highly favourable. In addition, the contribution of technical expertise and novel insights from material science to the dental and medical industries could foster future innovative collaborations between these industries and the University of Saskatchewan and Canada.
Programme
Engage Grants Program
Emplacement
Saskatchewan, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
401774-2010
Name nom
Wilson, Lee
Department département
Chemistry
Organization id
16
Institution établissement
University of Saskatchewan
Province en
Saskatchewan
Province fr
Saskatchewan
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2010
Competition year année de concours
2010
Award amount
23926
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1555
Committee name en
Prairie Internal Decision Committee
Committee name fr
Comité de décision interne pour les Prairies
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
3400
Research subject group en
Physical chemistry
Research subject group fr
Chimie physique
Research subject en
Physical chemistry
Research subject fr
Chimie physique
Partie
1
Nb partie
1
Application title
Therapeutic biomaterial composites
Keyword
NSERC
Application summary
The aim of this study is to evaluate the possible chemical interactions between ternary mixtures of these chemicals for development of novel therapeutic biomaterial formulations, and to produce a commercially viable product. Novel types of biomaterial composites derived from binary mixtures of a polysaccharide and a bioactive ketone will be formulated to produce a novel hemostatic agent. The projected outcome of this NSERC Engage research is an increase in the understanding of the chemistry of these agents which will lead to a better manipulation and the formulation of new biomaterial composites which have potential therapeutic application in the prevention and treatment of dry sockets. The NSERC Engage program provides an opportunity to develop new research, by supporting the proposed short-term project aimed at the development of novel therapeutic biomaterial formulations, and to commercialize a viable commercial product. A major social benefit to Canada is the development of improved biomaterial composites to treat dry socket and for hemostatic materials. The market demand for these materials is very high, the materials are novel, possessing additional properties, not typically found in existing products, and will enable us to overcome some of the undesirable properties present in commercially available products. Therefore, the anticipated economic benefits are wide ranging and are anticipated to be highly favourable. In addition, the contribution of technical expertise and novel insights from material science to the dental and medical industries could foster future innovative collaborations between these industries and the University of Saskatchewan and Canada.